Michael Joffre, Ph.D.

Michael Joffre, Ph.D.

Sterne, Kessler, Goldstein & Fox P.L.L.C.

Contact
View Bio
RSS

Latest Posts › Food and Drug Administration (FDA)

Share:

2024 Federal Circuit IP Appeals – Amarin Pharma, Inc. v. Hikma Pharm. USA Inc., 104 F.4th 1370 (Fed. Cir. 2024) (Moore, Lourie,...

Amarin sells the drug icosapent ethyl under the brand name Vascepa. Vascepa is approved by the FDA for two indications: (i) to treat severe hypertriglyceridemia, a condition characterized by blood triglyceride levels greater...more

2/18/2025  /  Appeals , Food and Drug Administration (FDA) , Intellectual Property Litigation , Life Sciences , Motion to Dismiss , Patent Infringement , Patent Litigation , Patents , Pharmaceutical Industry , Pharmaceutical Patents
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide